Tekmira Yesterday, Arbutus Today
Research - As we theorized early this month, Tekmira Pharmaceuticals (TKMR) is changing its name and re prioritizing drug development efforts around Hepatitis B. Unfortunately, our musings that investors may reward the … Continue Reading
Read now